Cerner sinks $266M into Lumeris as part of strategic partnership targeting Medicare Advantage plans

Cerner will become a minority owner in Lumeris' parent company and gain access to 65,000 Medicare Advantage beneficiaries. (Hookmeupbarb CC BY-SA 4.0)

Cerner will become a minority owner in the parent company of the population health services platform Lumeris as part of a 10-year strategic partnership that includes a new value-based technology offering geared towards Medicare Advantage plans.

The deal allows Cerner to tap into an established Medicare Advantage plan in Missouri, operated by Lumeris. The two companies plan to use data and digital processes to help providers “maximize outcomes” for patients enrolled in value-based arrangements, including Medicare Advantage and provider-sponsored plans. 

As part of the deal, Cerner subsidiary Cerner Capital will become a minority stakeholder in Lumaris’ parent company, Essence Group Holdings, purchasing $266 million in stock, according to a financial filing. The company also owns Essence Healthcare, a Lumeris-operated Medicare Advantage plan with 65,000 beneficiaries in Missouri.


2019 Drug Pricing and Reimbursement Stakeholder Summit

Given federal and state pricing requirements arising, press releases from industry leading pharma companies, and the new Drug Transparency Act, it is important to stay ahead of news headlines and anticipated requirements in order to hit company profit targets, maintain value to patients and promote strong, multi-beneficial relationships with manufacturers, providers, payers, and all other stakeholders within the pricing landscape. This conference will provide a platform to encourage a dialogue among such stakeholders in the pricing and reimbursement space so that they can receive a current state of the union regarding regulatory changes while providing actionable insights in anticipation of the future.

Together, Lumeris and Cerner plan to release an “EHR-agnostic” solution called Maestro Advantage, with deployments expected by the end of the year and broad market implementation in 2019. The companies plan to identify systems “best positioned to succeed with the offering, particularly large organizations pursuing multi-year growth strategies.”

Lumeris will also adopt Cerner’s HealtheIntent population health platform.

“By using data to reduce or eliminate unnecessary costs and ineffective transitions of care, providing doctors and their patients a more complete view of their medical history and a health plan that consistently receives high quality scores from CMS, this collaboration with Lumeris aligns well with our mission and illustrates the potential of Cerner technology to positively impact health care economics and outcomes in deeper, more impactful ways than before,” said Cerner CEO Brent Shafer.

RELATED: VA signs $10B deal with Cerner, but implementation challenges still loom large

John Doerr, Lumeris board member and chairman of Kleiner Perkins added that the value-based care transition has been “impeded by disjointed technology, cumbersome processes, misaligned incentives and inadequate management of clinical and financial outcomes,” pointing to the partnership’s focus on data transparency and provider empowerment.

The population health management market is expected to grow rapidly over the next decade, reaching $69 billion by 2025, according to Transparency Market Research.

Suggested Articles

We need our federal programs and policies to reflect the goal of improving the health of both women and men.

Two lawsuits were filed suing the Trump administration to overturn a new rule that would allow healthcare workers to deny care over religious or conscience…

Policy changes are affecting how investors view the skilled home health market and paving the way for potential strategic acquisitions.